Catalent completes Juniper merger to ‘expand and strengthen’ oral dose manufacturing 14-Aug-2018 By Flora Southey Juniper Pharmaceuticals will become a wholly owned subsidiary of Catalent Pharma Solutions today, says the CDMO.